Literature DB >> 10201584

The natural history of macular edema after cataract surgery in diabetes.

J G Dowler1, K S Sehmi, P G Hykin, A M Hamilton.   

Abstract

OBJECTIVE: To determine the natural history of macular edema after cataract surgery in diabetes to provide a rational basis for laser therapy.
DESIGN: Prospective clinical and angiographic trial. PARTICIPANTS: Thirty-two patients with diabetes undergoing cataract surgery. INTERVENTION: Phacoemulsification surgery with intraoperative fluorescein angiography, and postoperative clinical and angiographic assessment without macular laser therapy for 1 year after surgery. MAIN OUTCOME MEASURES: Clinically significant macular edema, postoperative macular and optic disc hyperfluorescence relative to the intraoperative angiogram, and logarithm of the minimum angle of resolution (LogMAR) visual acuity.
RESULTS: In the first postoperative year, macular fluorescence remained at its intraoperative level in 2 (6%) of 32 eyes and increased in 30 (94%) of 32 eyes, returning to its intraoperative level within 1 year of surgery in 13 (43%) of 30 eyes. Optic disc fluorescence remained at its intraoperative level in 2 (6%) of 32 eyes, was not graded in 3 (9%) of 32 eyes, and increased in 27 (84%) of 32 eyes, returning to its intraoperative level within 1 year of surgery in 19 (70%) of 27 eyes. Clinically significant macular edema was identified in the first postoperative year in 18 (56%) of 32 eyes, being present at the time of surgery in 5 eyes and arising de novo within 1 year of surgery in 13 eyes. It resolved spontaneously within 1 year of surgery in 0 of 5 eyes in which it had been present at the time of surgery and in 9 (69%) of 13 eyes in which it arose in the first 6 months after surgery (P = 0.05). Angiographic and clinical resolutions of macular edema were less likely in eyes with more severe retinopathy at the time of surgery (P = 0.03, 0.005). One-year LogMAR acuity of 0.3 or less (> or = 20/40) was achieved in 27 (84%) of 32 eyes. Clinically significant macular edema at the time of surgery was associated with poorer 1-year visual acuity in multivariate analysis (P = 0.005, r2 = 0.5).
CONCLUSIONS: Clinically significant macular edema present in diabetic eyes at the time of cataract surgery is unlikely to resolve spontaneously, but clinically significant macular edema arising after surgery commonly resolves, particularly if retinopathy is mild. These findings have implications for the timing of cataract surgery in diabetes and postoperative macular laser therapy. Ophthalmology 1999;106:663-668

Entities:  

Mesh:

Year:  1999        PMID: 10201584     DOI: 10.1016/S0161-6420(99)90148-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting.

Authors:  Eleonora Corbelli; Francesco Fasce; Lorenzo Iuliano; Riccardo Sacconi; Rosangela Lattanzio; Francesco Bandello; Giuseppe Querques
Journal:  Acta Diabetol       Date:  2020-05-04       Impact factor: 4.280

2.  [Cataract surgery. Effect on the posterior segment of the eye].

Authors:  W A Herrmann; H Heimann; H Helbig
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

3.  Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls.

Authors:  Urban Eriksson; Albert Alm; Gunilla Bjärnhall; Elisabet Granstam; Anna Wikberg Matsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-09       Impact factor: 3.117

4.  Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects.

Authors:  Robert F Degenring; Sonja Vey; Bernd Kamppeter; Wido M Budde; Jost B Jonas; Gangolf Sauder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-25       Impact factor: 3.117

5.  A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes.

Authors:  D Squirrell; R Bhola; J Bush; S Winder; J F Talbot
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

Review 6.  Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

Authors:  Ebru Nevin Cetin; Cem Yıldırım
Journal:  Int Ophthalmol       Date:  2012-12-18       Impact factor: 2.031

Review 7.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

8.  Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy.

Authors:  Ahmad Mansour; Ziad F Bashshur; Tarek A Sibai; Abla Mehio-Sibai; Rola N Hamam
Journal:  Oman J Ophthalmol       Date:  2011-01

9.  Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.

Authors:  Rishi Singh; Louis Alpern; Glenn J Jaffe; Robert P Lehmann; John Lim; Harvey J Reiser; Kenneth Sall; Thomas Walters; Dana Sager
Journal:  Clin Ophthalmol       Date:  2012-08-03

10.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.